Ulrike Thull

809 total citations
16 papers, 677 citations indexed

About

Ulrike Thull is a scholar working on Organic Chemistry, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ulrike Thull has authored 16 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 6 papers in Neurology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ulrike Thull's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Synthesis and Biological Evaluation (4 papers). Ulrike Thull is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Synthesis and Biological Evaluation (4 papers). Ulrike Thull collaborates with scholars based in Switzerland, Italy and United Kingdom. Ulrike Thull's co-authors include Bernard Testa, Cosimo Altomare, Angelo Carotti, Pierre‐Alain Carrupt, Saverio Cellamare, Kevin St. P. McNaught, H. Stoeckli‐Evans, Kurt Hostettmann, Bernard Testa and Pierre‐Alain Carrupt and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Phytochemistry.

In The Last Decade

Ulrike Thull

16 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Thull Switzerland 14 272 210 166 160 142 16 677
Jeffrey Sterling Israel 15 536 2.0× 334 1.6× 142 0.9× 182 1.1× 34 0.2× 19 998
Dong Jin Kim South Korea 18 313 1.2× 517 2.5× 109 0.7× 186 1.2× 34 0.2× 33 1.1k
Se‐Young Son South Korea 4 208 0.8× 268 1.3× 85 0.5× 181 1.1× 49 0.3× 7 631
José L. Marco Spain 21 693 2.5× 417 2.0× 44 0.3× 279 1.7× 171 1.2× 62 1.1k
Umberto Maria Battisti Denmark 16 362 1.3× 383 1.8× 67 0.4× 98 0.6× 56 0.4× 68 808
Y. Kondou Japan 4 209 0.8× 333 1.6× 85 0.5× 183 1.1× 27 0.2× 7 719
José A. Fontenla Spain 16 306 1.1× 231 1.1× 45 0.3× 130 0.8× 20 0.1× 36 610
E. FERNANDEZ‐ALVAREZ Spain 18 566 2.1× 205 1.0× 56 0.3× 110 0.7× 14 0.1× 52 786
Doris Feineis Germany 23 801 2.9× 510 2.4× 141 0.8× 181 1.1× 100 0.7× 83 1.4k
Nuria Fraiz Spain 11 397 1.5× 174 0.8× 32 0.2× 124 0.8× 27 0.2× 17 674

Countries citing papers authored by Ulrike Thull

Since Specialization
Citations

This map shows the geographic impact of Ulrike Thull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Thull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Thull more than expected).

Fields of papers citing papers by Ulrike Thull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Thull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Thull. The network helps show where Ulrike Thull may publish in the future.

Co-authorship network of co-authors of Ulrike Thull

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Thull. A scholar is included among the top collaborators of Ulrike Thull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Thull. Ulrike Thull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Carotti, Andrea, Marco Catto, Francesco Leonetti, et al.. (2007). Synthesis and Monoamine Oxidase Inhibitory Activity of New Pyridazine-, Pyrimidine- and 1,2,4-Triazine-Containing Tricyclic Derivatives. Journal of Medicinal Chemistry. 50(22). 5364–5371. 35 indexed citations
2.
Gnerre, Carmela, Ulrike Thull, Patrick Gaillard, et al.. (2001). Natural and Synthetic Xanthones as Monoamine Oxidase Inhibitors: Biological Assay and 3D-QSAR. Helvetica Chimica Acta. 84(3). 552–570. 68 indexed citations
3.
Thull, Ulrike, Pierre‐Alain Carrupt, & Bernard Testa. (1998). Pargyline Analogues as Potent, Non‐selective Monoamine Oxidase Inhibitors. Pharmacy and Pharmacology Communications. 4(12). 579–581. 6 indexed citations
4.
Altomare, Cosimo, Saverio Cellamare, Luciana Summo, et al.. (1998). Inhibition of Monoamine Oxidase-B by Condensed Pyridazines and Pyrimidines:  Effects of Lipophilicity and Structure−Activity Relationships. Journal of Medicinal Chemistry. 41(20). 3812–3820. 73 indexed citations
5.
McNaught, Kevin St. P., Ulrike Thull, Pierre‐Alain Carrupt, et al.. (1996). Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience Letters. 206(1). 37–40. 24 indexed citations
6.
McNaught, Kevin St. P., Ulrike Thull, Pierre‐Alain Carrupt, et al.. (1996). Nigral Cell Loss Produced by Infusion of Isoquinoline Derivatives Structurally Related to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine. PubMed. 5(3). 265–274. 20 indexed citations
7.
McNaught, Kevin St. P., Ulrike Thull, Pierre‐Alain Carrupt, et al.. (1996). Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration. Biochemical Pharmacology. 51(11). 1503–1511. 34 indexed citations
8.
McNaught, Kevin St. P., Ulrike Thull, Pierre‐Alain Carrupt, et al.. (1996). Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Biochemical Pharmacology. 52(1). 29–34. 28 indexed citations
10.
Thull, Ulrike, et al.. (1995). Inhibition of Monoamine Oxidase-B by 5H-Indeno[1,2-c]pyridazines: Biological Activities, Quantitative Structure-Activity Relationships (QSARs) and 3D-QSARs. Journal of Medicinal Chemistry. 38(19). 3874–3883. 55 indexed citations
11.
McNaught, Kevin St. P., Cosimo Altomare, Saverio Cellamare, et al.. (1995). Inhibition of α-Ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroreport. 6(8). 1105–1108. 36 indexed citations
12.
Thull, Ulrike, Patrick Gaillard, Pierre‐Alain Carrupt, et al.. (1995). Inhibition of monoamine oxidase by isoquinoline derivatives. Biochemical Pharmacology. 50(6). 869–877. 52 indexed citations
13.
McNaught, Kevin St. P., Ulrike Thull, Pierre‐Alain Carrupt, et al.. (1995). Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP). Biochemical Pharmacology. 50(11). 1903–1911. 49 indexed citations
14.
Rocha, Leandro, Andrew Marston, H. Stoeckli‐Evans, et al.. (1994). An antifungal γ-pyrone and xanthones with monoamine oxidase inhibitory activity from Hypericum brasiliense. Phytochemistry. 36(6). 1381–1385. 97 indexed citations
15.
Thull, Ulrike & Bernard Testa. (1994). Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases. Biochemical Pharmacology. 47(12). 2307–2310. 67 indexed citations
16.
Thull, Ulrike, et al.. (1993). Substituted Xanthones as Selective and Reversible Monoamine Oxidase A (MAO-A) Inhibitors. Pharmaceutical Research. 10(8). 1187–1190. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026